Can we rely on the dermatology life quality index as a measure of the impact of psoriasis or atopic dermatitis

Journal of Investigative Dermatology

Volumn 132, Issue 1, 2012, Pages 76-84

  Twiss, James ^a   Meads, David M ^a   Preston, Elizabeth P ^a   Crawford, Sigrid R ^a   McKenna, Stephen P ^a  

^a GALEN RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; DERMATOLOGY LIFE QUALITY INDEX; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SKIN DISEASE;

EID: 84856113401     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.238     Document Type: Article

References (42)

1. Andrich D (1978) Rating formulation for ordered response categories. Psychometrika 43:561-73
2. Andrich D (2004) Controversy and the Rasch model: a characteristic of incompatible paradigms? Medical Care 42(Suppl S1):1-7
3. Andrich D, Sheridan B, Ludo G (2005) Rasch Unidimensional Measurement Models: A Windows-Based Item Analysis Program Employing Rasch Models (RUMM2020). Perth, Australia: Murdoch University
4. Basra MKA, French R, Gatt RM et al. (2008) The dermatology Life Quality Index 1994-2007: a comprehensive review of validation and clinical results. Br J Dermatol 159:997-1035
5. Brodersen J, Thorsen H, Kreiner S (2010) Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health 13:601-12
6. Chren MM, Lasek RJ, Flocke SA et al. (1997) Improved discriminative and evaluative capability of a refined version of Skindex, a quality of-life instrument for patients with skin diseases. Arch Dermatol 133: 1433-40 (Pubitemid 27490569)
7. Dallmeijer AJ, dr Groot V, Roorda LD et al., FuPro Study Group (2007) Crossdiagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis and amyotrophic lateral sclerosis: a study using Rasch analysis. J Rahabil Med 39:163-9
8. Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19: 210-6 (Pubitemid 24194579)
9. Hambleton RK (2006) Good practices for identifying differential item functioning. Med Care 44:S182-8 (Pubitemid 44632044)
10. Holland PW, Wainer H (eds) (1993) Differential Item Functioning. New Jersey: Lawrence Erlbaum Associates
11. Hunt SM, McKenna SP (1992) The QLDS: a scale for the measurement of quality of life in depression. Health Policy 22:307-19
12. Lewis V, Finlay AY (2004) Ten years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 9:169-80 (Pubitemid 38457276)
13. Linacre JM (1994) Sample size and item calibration stability. Rasch Measurement Trans 7:4. p.328
14. Ludwig MW, Oliveira Mda S, Muller MC et al. (2009) Quality of life and site of the lesion in dermatological patients. An Bras Dermatol 84: 143-50
15. Luquet C, Chau N, Guillemin F et al. (2001) A method for shortening instruments using the Rasch model. Validation on a hand functional measure. Rev Epidemiol Sante Publique 49:273-86
16. Masters G (1982) A Rasch model for partial credit scoring. Psychometrika 47:149-74
17. Mazzotti E, Barbaranelli C, Picardi A et al. (2005) Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis. Acta Derm Venereol 85:409-13 (Pubitemid 41345614)
18. McKenna SP, Cook SA, Whalley D et al. (2003) Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol 149:323-31 (Pubitemid 37100259)
19. National Institute for Health and Clinical Excellence (2008a) Infliximab for the treatment of adults with psoriasis. NICE Technology Appraisal Guidance 134
20. National Institute for Health and Clinical Excellence (2008b) Adalimumab for the treatment of adults with psoriasis. NICE Technology Appraisal Guidance 146
21. National Institute for Health and Clinical Excellence (2009) Ustekinumab for the treatment of adults with moderate to severe psoriasis. NICE Technology Appraisal Guidance 180
22. Nijsten T, Meads DM, de Korte J et al. (2007) Cross-cultural inequivalence of dermatology-specific health related quality of life instruments in psoriasis patients. J Invest Dermatol 127:2315-22 (Pubitemid 47619752)
23. Nijsten T, Meads DM, McKenna SP (2006a) Dimensionality of the dermatology life quality index (DLQI): a commentary. Acta Derm Venereol 86:284-5; author reply 285-6 (Pubitemid 43875235)
24. Nijsten TE, Sampogna F, Chren MMet al. (2006b) Testing and reducing skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 126:1244-50 (Pubitemid 43997903)
25. Pallant JF, Tennant A (2007) An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 46:1-18 (Pubitemid 46332274)
26. Papoutsaki M, Chimenti MS, Costanzo A et al. (2007) Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics. J Am Acad Dermatol 57:269-75 (Pubitemid 47048857)
27. Potocka A, Turczyn-Jabtońska K, Kieć-Swierczyńska M (2008) Self-image and quality of life of dermatology patients. Int J Occup Med Environ Health 21:309-17
28. Potocka A, Turczyn-Jabloñska K, Merecz D (2009) Psychological correlates of quality of life in dermatology patients: the role of mental health and selfacceptance. Acta Dermatovenerol Alp Panonica Adriat 18:53-8
29. Prieto L, Alonso J, Lamarca R (2003) Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health Qual Life Outcomes 1:27
30. Quandt SA, Schulz MR, Vallejos QM et al. (2008) The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant farmworkers. Int J Dermatol 47:236-41 (Pubitemid 351266840)
31. Raczek AE, Ware JE, Bjorner JB et al. (1998) Comparison of Rasch and summated rating scales constructed from the SF-36 physical functioning items in seven countries: results from the IQOLA project. J Clin Epidemiol 51:1203-14 (Pubitemid 28527176)
32. Rasch G (1960) (Reprinted 1980) Probabilistic Models for Some Intelligence and Attainment Tests. Chicago: University of Chicago Press
33. Schmitt J, Heese E, Wozel G et al. (2007) Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris-a prospective study. Dermatology 214:68-76 (Pubitemid 46033004)
34. Smith AB, Wright EP, Rush R et al. (2006) Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale. Psychoonconology 15:817-27 (Pubitemid 44404641)
35. Smith CH, Anstey AV, Barker JN et al. (2005) British Association of Dermatologists Guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 153:486-97 (Pubitemid 41248202)
36. Smith CH, Anstey AV, Barker JN et al. (2009) British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 161:987-1019
37. Tennant A, Gonaghan PG (2007) The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one should one look for in a Rasch paper? Arthritis Rheum 57:1358-62 (Pubitemid 350308830)
38. Tennant A, McKenna SP, Hagell P (2004) Application of Rasch analysis in the development and application of quality of life instruments. Value Health 7(Suppl 1):S22-6 (Pubitemid 39390826)
39. Waugh RF, Chapman ES (2005) An analysis of dimensionality using factor analysis (true-score theory) and Rasch measurement: what is the difference? Which method is better? J Appl Meas 6:80-99 (Pubitemid 40201893)
40. Whalley D, McKenna SP, Dewar AL et al. (2004) A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 150:274-83 (Pubitemid 38352465)
41. Wright BD (1996) Comparing Rasch measurement and factor analysis. Structural Equation Modelling 3:3-24
42. Wright BD, Tennant A (1996) Sample size again. Rasch Measurement Transactions 9:4. (p468) http://www.rasch.org/rmt/rmt74m.htm accessed 30 November 2009